Vantage Consulting Group’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-805
Closed -$239K 109
2024
Q2
$239K Buy
805
+159
+25% +$54K 0.18% 109
2024
Q1
$265K Sell
646
-31
-5% -$12K 0.17% 90
2023
Q4
$245K Sell
677
-148
-18% -$52.2K 0.16% 129
2023
Q3
$271K Sell
825
-96
-10% -$30.2K 0.18% 97
2023
Q2
$277K Sell
921
-117
-11% -$33.6K 0.16% 95
2023
Q1
$278K Buy
1,038
+233
+29% +$67K 0.16% 95
2022
Q4
$266K Sell
805
-29
-3% -$9.85K 0.16% 101
2022
Q3
$275K Sell
834
-148
-15% -$47.7K 0.16% 91
2022
Q2
$275K Buy
982
+151
+18% +$45.6K 0.15% 93
2022
Q1
$277K Buy
+831
New +$256K 0.11% 100
2021
Q1
Sell
-84
Closed -$18K 989
2020
Q4
$18K Buy
+84
New +$17.3K ﹤0.01% 924

Other funds holding MOH

Vantage Consulting Group's MOH Position: Q3 2024 in Review

Vantage Consulting Group sold out of Molina Healthcare (MOH) in Q3 2024, closing a stake of 805 shares — an estimated $239K sold.

Vantage Consulting Group first reported a position in MOH in Q4 2020 and held it in 11 quarters. The position peaked at $278K in Q1 2023. 616 funds tracked by Wall St. Rank hold MOH as of Q3 2024.

  • Vantage Consulting Group reported no remaining Molina Healthcare position as of Q3 2024 after selling out during the quarter.
  • Vantage Consulting Group sold 805 Molina Healthcare shares in Q3 2024, an estimated $239K.
  • Vantage Consulting Group first reported a position in Molina Healthcare in Q4 2020 and held it in 11 quarters.
  • Vantage Consulting Group's Molina Healthcare position peaked at $278K in Q1 2023.
  • 616 funds tracked by Wall St. Rank held Molina Healthcare as of Q3 2024.

Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.